Abstract:Mycobacterium tuberculosis (Mtb) ATP synthase is an important target for treating drug-resistant infections and sterilizing the bacteria, spurring intensive efforts to develop new TB therapeutics based on this target. In this work, four novel series including furan-2(5H)-ketone (3, 4), maleimide (5) and squaramide (6) derivatives were designed, respectively, through the strategy of scaffold morphing and hydrogen-bond introduction, using the selective Mtb ATP synthase inhibitor compound 2 as the lead compound. The result demonstrated that diamino substituted cyclobut-3-ene-1,2-dione compounds 6ab and 6ah displayed good to excellent in vitro anti-TB activities (MIC 0.452 ∼ 0.963 μg/mL) with low cytotoxicity (IC50 > 64 μg/mL). In addition, not only did compound 6ab show effective activity against clinically isolated resistant strains, it also revealed good druggability profiles including improved metabolic stability, no hERG channel inhibition potential, and acceptable oral bioavailability. The preliminary result of docking study and in vitro anti-bedaquiline-resistant strain test compared to compound 2 suggested that Mtb ATP synthase is most likely the target of compound 6ab. The structure-activity relationship laid a good foundation for the identification of novel squaramides as a potential treatment of drug-resistant tuberculosis.

Recent Advances of Imidazole-Containing Derivatives As Anti-Tubercular Agents

Recent Advances in the Research of Heterocyclic Compounds As Antitubercular Agents

Isatin Derivatives with Potential Antitubercular Activities

Discovery of New Chemical Entities As Potential Leads Against Mycobacterium Tuberculosis.

Recent Advances in Antitubercular Compounds Targeting Mycolic Acid Biosynthesis and Transport

Advances in the Research of Anti-Tuberculosis Drugs

Design, Synthesis, and Biological Evaluation of Pyrazolo[1,5-a]pyridine-3-carboxamides As Novel Antitubercular Agents.

Design, synthesis and biological evaluation of diamino substituted cyclobut-3-ene-1,2-dione derivatives for the treatment of drug-resistant tuberculosis

Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents

Design, synthesis, and biological evaluation of m-amidophenol derivatives as a new class of antitubercular agents.

Synthesis and Biological Evaluation of Arylthiourea Derivatives with Antitubercular Activity

Isatin hybrids and their anti-tuberculosis activity

Progress in Studies of Anti-tubercular Nitroimidazoles

Recent progress on pyrazole scaffold-based antimycobacterial agents

Opportunities and challenges of using five-membered ring compounds as promising antitubercular agents

Progress in the Research of Anti-Tuberculosis Drugs

Isoniazid Analogs and Their Biological Activities as Antitubercular Agents (A Review)

Design, synthesis and biological evaluation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against Mycobacterium tuberculosis protein tyrosine phosphatase B

Synthesis and Antitubercular Evaluation of Reduced Lipophilic Imidazo[1,2-A]pyridine-3-carboxamide Derivatives

Synthesis and Evaluation of Nitrofuranyl Methyl N-heterocycles Derivatives As Novel Antitubercular Agents

Design, Synthesis, and Evaluation of the Antitubercular Activity of 5-Phenyl Substituted-5, 6-dihydropyrido[2, 3- d ]pyrimidine-4, 7( 3H , 8H )-dione Compounds